Trial Profile
Aripiprazole Added on Methylphenidate in the Treatment of Youths With Comorbid ADHD and DMDD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2017
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Methylphenidate (Primary)
- Indications Attention deficit and disruptive behaviour disorders
- Focus Therapeutic Use
- Acronyms AAOFDIYWA
- 05 Dec 2017 New trial record